Published in Dev Dyn on December 01, 2007
Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res (2009) 1.96
Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells (2008) 1.80
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood (2008) 1.62
Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc (2009) 1.59
Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev (2009) 1.41
Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J Transl Med (2008) 1.38
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol (2008) 1.36
Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol (2009) 1.21
Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol (2008) 1.00
Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater (2011) 0.93
Secretome of peripheral blood mononuclear cells enhances wound healing. PLoS One (2013) 0.91
The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med (2008) 0.90
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials. Kidney Int Suppl (2011) (2011) 0.88
Stem cells for heart failure in the aging heart. Heart Fail Rev (2010) 0.86
Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering. Biologics (2012) 0.86
Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations. Stem Cell Res Ther (2013) 0.85
Mesenchymal stem cells for treatment of myocardial infarction. Int J Stem Cells (2008) 0.83
Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. Biomed Res Int (2015) 0.82
Aconiti Lateralis Preparata Radix Activates the Proliferation of Mouse Bone Marrow Mesenchymal Stem Cells and Induces Osteogenic Lineage Differentiation through the Bone Morphogenetic Protein-2/Smad-Dependent Runx2 Pathway. Evid Based Complement Alternat Med (2013) 0.82
Genetic investigation of biological materials from patients after stem cell transplantation based on autosomal as well as Y-chromosomal markers. Int J Legal Med (2012) 0.80
Characterization of mononucleated human peripheral blood cells. ScientificWorldJournal (2012) 0.80
Effects of herbal Epimedium on the improvement of bone metabolic disorder through the induction of osteogenic differentiation from bone marrow-derived mesenchymal stem cells. Mol Med Rep (2016) 0.75
Sourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applications. Mol Ther (2014) 0.75
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 6.71
Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol (2007) 3.54
Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int (2005) 2.29
Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int (2005) 2.24
Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev (2009) 1.41
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol (2008) 1.36
VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med (2008) 1.14
Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol (2010) 1.14
In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging (2007) 1.12
Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am J Kidney Dis (2012) 1.09
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci U S A (2006) 1.05
Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J Am Soc Nephrol (2004) 0.91
Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. Stem Cells Dev (2010) 0.85
Extent of glomerular tubularization is an indicator of the severity of experimental acute kidney injury in mice. Nephron Exp Nephrol (2006) 0.83
The role of multipotent marrow stromal cells (MSCs) in tissue regeneration. Organogenesis (2011) 0.80
Administration of poly-D-glutamic acid induces proliferation of erythropoietin-producing peritubular cells in rat kidney. Am J Physiol Renal Physiol (2006) 0.79